Lay summary
Keratoconus (KC) causes significant visual impairment and disproportionately affects Māori and Pacific peoples. Corneal crosslinking (CXL) is a minor procedure and an effective treatment for KC. However, demand for CXL far exceeds current capacity in the tertiary setting. This research aims to (1) evaluate a newer CXL process (which will enable CXL delivery in the community, where capacity is greater) and (2) implement a community service delivering this newer CXL, in an area with large Māori and Pacific communities and high deprivation neighbourhoods. This research will improve CXL capacity while reducing hospital resources needed, improving health service cost-effectiveness and efficiency. This research will also improve eye care equity and eye health outcomes.